Abstract
AimsTo assess diabetes care delivery and prevention of short- and long-term diabetes-related complications in patients with type 2 diabetes mellitus (T2DM) in Vietnam.MethodsDiabCare Asia is an observational, non-interventional, cross-sectional study of hospital-based outpatient care for patients diagnosed with T2DM.ResultsA total of 1631 patients (mean age 62.7 years; 58.9% female) participated in the study. The percentage of patients with HbA1c < 7.0% (< 53 mmol/mol) was 36.1% and mean (standard deviation) HbA1c was 7.9 ± 1.8% (63 ± 19 mmol/mol). The proportion of patients using insulin was 40%, at a mean total daily dose of 35.4 U. Apart from dyslipidemia (81.2%) and hypertension (78.4%), the most common diabetes-related complications were peripheral neuropathy (37.9%) and eye complications (39.5%). Current insulin therapy was associated with peripheral vascular disease (odds ratio [OR] = 2.28 [95% confidence interval (CI) 1.68; 3.09]) and eye complications (OR = 1.70 [95% CI 1.37; 2.11]).ConclusionIn this sample of patients with T2DM in Vietnam, the majority had poor glycemic and metabolic control. Concerted efforts are needed to optimize control and prevent complications in these patients. Trial registration: NCT02066766
Highlights
In 2017, there were 425 million people diagnosed with diabetes worldwide
Between 1990 and 2010, the total disability-adjusted life years (DALYs), a measure of overall disease burden, attributable to diabetes increased by nearly 70%, while DALYs attributed to cardiovascular disease (CVD) and cancer each increased by approximately 25% in the Asia-Pacific region [5]
DiabCare Asia was an observational, non-interventional, cross-sectional study conducted in Bangladesh, Indonesia, Malaysia, Philippines, Sri Lanka, and Vietnam (Clinicaltrials.gov registration number: NCT02066766)
Summary
In 2017, there were 425 million people diagnosed with diabetes worldwide. The prevalence of diabetes in both regions already exceeds that of Europe, South and Central America, and Africa, and, by 2045, the prevalence in the Western Pacific region is expected to reach 183 million [1]. Undiagnosed diabetes represents a significant health problem [2], leading to an increase in the burden of disease, which includes diabetesrelated complications. Diabetes presents significant challenges to developing countries in the above regions [2,3,4,5]. Between 1990 and 2010, the total disability-adjusted life years (DALYs), a measure of overall disease burden, attributable to diabetes increased by nearly 70%, while DALYs attributed to cardiovascular disease (CVD) and cancer each increased by approximately 25% in the Asia-Pacific region [5]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Diabetes in Developing Countries
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
